S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
about
The life and works of S100P - from conception to cancerGene expression profiling of breast cancer in Lebanese women.Distinct prognostic values of S100 mRNA expression in breast cancer.HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study.
P2860
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
@en
type
label
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
@en
prefLabel
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
@en
P2093
P50
P1476
S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer.
@en
P2093
Akos Szabo
Christof Sohn
Joachim Rom
Mark Kriegsmann
Markus Wallwiener
Melanie Maierthaler
Rongxi Yang
Sarah Jauch
P304
P356
10.1016/J.YEXMP.2015.06.010
P577
2015-06-22T00:00:00Z